| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 96 |
| 1 | PREDNISONE | 95 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 90 |
| 3 | TACROLIMUS OINTMENT 0.1% | 90 |
| 4 | MYCOPHENOLATE MOFETIL | 49 |
| 5 | PREDNISOLONE | 26 |
| 6 | PREDNISOLONE ORAL | 26 |
| 7 | PREDNISOLONE ORAL SOLUTION | 26 |
| 8 | METHYLPREDNISOLONE | 24 |
| 9 | POSACONAZOLE | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PENTAMIDINE ISETHIONATE | 9 | 0.0073 |
| 1 | FLUCYTOSINE | 8 | 0.0058 |
| 2 | PYRIMETHAMINE | 7 | 0.0055 |
| 3 | ATOVAQUONE | 17 | 0.0021 |
| 4 | CARMUSTINE | 8 | 0.0017 |
| 5 | CYCLOPENTOLATE HYDROCHLORIDE | 1 | 0.0016 |
| 6 | GANCICLOVIR SODIUM | 16 | 0.0015 |
| 7 | POSACONAZOLE | 23 | 0.0014 |
| 8 | DACARBAZINE | 8 | 0.0011 |
| 9 | ALEMTUZUMAB | 20 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 136 |
| 1 | Azole Antifungal [EPC] | 53 |
| 2 | Alkylating Drug [EPC] | 30 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 21 |
| 4 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 21 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 20 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 20 |
| 7 | Antimalarial [EPC] | 17 |
| 8 | Antiprotozoal [EPC] | 17 |
| 9 | Nucleoside Analog Antiviral [EPC] | 17 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nucleoside Analog Antifungal [EPC] | 8 | 0.0058 |
| 1 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 7 | 0.0055 |
| 2 | Sulfonamide Antibacterial [EPC] | 7 | 0.0018 |
| 3 | Antimalarial [EPC] | 17 | 0.0017 |
| 4 | Antiprotozoal [EPC] | 17 | 0.0016 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 20 | 0.0010 |
| 6 | Antimetabolite Immunosuppressant [EPC] | 20 | 0.0010 |
| 7 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 21 | 0.0010 |
| 8 | CD30-directed Immunoconjugate [EPC] | 8 | 0.0008 |
| 9 | Azole Antifungal [EPC] | 53 | 0.0003 |